Clinical Trial Update: Nivolumab+Ipilimumab+RT in MSS mCRC [Phase 2]

View source ↗

Summary

Phase 2 trial update examining nivolumab + ipilimumab + radiotherapy in metastatic microsatellite stable colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Microsatellite-stable Colorectal Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metastatic Microsatellite Stable Colorectal Cancer | Phase 2 | Status: UNKNOWN